Michael F. Coleman

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Kirsten L. Bryant · 2 shared papers, 2022 · strength 0.39
   • Paper Susceptibility to autophagy inhibition is enhanced by dual IGF1R and MAPK/ERK inhibition in pancreatic cancer. DOI 10.1080/15548627.2022.2042782↗
   • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
2. Clint A. Stalnecker · 2 shared papers, 2022 · strength 0.39
   • Paper Susceptibility to autophagy inhibition is enhanced by dual IGF1R and MAPK/ERK inhibition in pancreatic cancer. DOI 10.1080/15548627.2022.2042782↗
   • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
3. Stephen D Hursting · 2 shared papers, 2021–2022 · strength 0.26
   • Paper β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreat… DOI 10.3390/cancers13246359↗
   • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
4. Zhengrong Cui · 1 shared paper, 2021 · strength 0.13
   • Paper β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreat… DOI 10.3390/cancers13246359↗
5. Laura M. Lashinger · 1 shared paper, 2021 · strength 0.13
   • Paper β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreat… DOI 10.3390/cancers13246359↗
6. Kristyn A. Liu · 1 shared paper, 2021 · strength 0.13
   • Paper β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreat… DOI 10.3390/cancers13246359↗
7. Xiaohu Tang · 1 shared paper, 2021 · strength 0.13
   • Paper β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreat… DOI 10.3390/cancers13246359↗
8. Jonathan M. DeLiberty · 1 shared paper, 2022 · strength 0.13
   • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
9. Bjoern Papke · 1 shared paper, 2022 · strength 0.13
   • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
10. Emanuel F. Petricoin · 1 shared paper, 2022 · strength 0.13
    • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
11. A. Cole Edwards · 1 shared paper, 2022 · strength 0.13
    • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
12. Mariaelena Pierobon · 1 shared paper, 2022 · strength 0.13
    • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
13. Adrienne D. Cox · 1 shared paper, 2022 · strength 0.13
    • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
14. Channing J. Der · 1 shared paper, 2022 · strength 0.13
    • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗
15. Craig M. Goodwin · 1 shared paper, 2022 · strength 0.13
    • Paper Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. DOI 10.1158/0008-5472.can-21-1443↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.